CHRN on XNAS, Manufacturing, ChronoScale Holdings Corporation, job postings
Measures activity, not value. Not investment advice.
Quarterly revenue rose 148% to $41.5M but the stock has fallen 52% in a month.
BadTwelve-month net loss of $81.6M on $96.4M revenue
Watch2 director or officer changes filed in the last 90 days
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 31 Aug 2026
ChronoScale Holdings Corp is providing cloud services to customers at third-party colocation centers located in Colorado, Minnesota and Utah, such as artificial intelligence and machine learning developers, seeking to develop their products. It design, develop, and market exoskeleton and complementary products that augment human strength, endurance, and mobility. Its Cloud Business provides graphics processing unit (GPU) computing solutions that enable customers to execute critical workloads related to artificial intelligence (AI), machine learning (ML), rendering, and other High Performance Computing (HPC) tasks at scale in a capacity-constrained market. It has one operating segment Cloud Business.
Industry
General industrial machinery & equipment, nec (Manufacturing)
expected around 16 Feb 2027 (an estimate: a year ago it reported on 17 Feb 2026)
Revenue and net income per quarter. Quarter to 31 Aug 2026: revenue $41.5M, net loss $42.5M.
31 Dec 2021RevenueNet incomeNet losstallest bar $42.5M31 Aug 2026
See the numbers
Quarter to
Revenue
Net income
31 Aug 2026
$41.5M
-$42.5M
31 Mar 2026
$2.1M
-$6.9M
31 Dec 2025
$3.1M
-$4.7M
30 Sep 2025
$4.2M
-$1.4M
31 Aug 2025
$16.7M
-$11.2M
30 Jun 2025
$2.1M
-$2.7M
31 Mar 2025
$3.4M
-$2.9M
31 Dec 2024
$5.1M
-$3.4M
30 Sep 2024
$4.1M
-$2.1M
30 Jun 2024
$5.0M
-$2.4M
31 Mar 2024
$3.8M
-$3.4M
31 Dec 2023
$4.8M
-$3.2M
30 Sep 2023
$4.6M
-$3.4M
30 Jun 2023
$4.7M
-$4.2M
31 Mar 2023
$4.1M
-$4.4M
31 Dec 2022
$3.6M
-$3.2M
30 Sep 2022
$3.3M
-$4.3M
30 Jun 2022
$3.5M
-$3.0M
31 Mar 2022
$2.6M
-$4.6M
31 Dec 2021
–
-$2.9M
Fundamentals, 12 months to 31 Aug 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$96.4M
–
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
–
+11%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$81.6M
–
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$0.57
–
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
-14.6%
–
37.8%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
-56.4%
–
0.9%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-84.6%
–
2.1%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-68.0%
2.7%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
–
–
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$15.2M
$7K
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$10.7M
–
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
-$4.5M (net cash)
–
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.07
0.04
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$1.03
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
30.8
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
12.0
5.1
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
12.0
3.1
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
7.7
2.1
Latest = 12 months to 31 Aug 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+11%
50 13F filers vs 45
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
1.2%
1.7M shares held by 13F filers (30 Sep 2026) of 145.6M outstanding (13 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
0.4%
598K shares sold short (30 Oct 2026) of 145.6M outstanding (13 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
4.4
598K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-6.8%
642K shares sold short in the report before, 598K on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
79%
79% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 60%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+148%
$41.5M vs $16.7M (quarter ended 31 Aug 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
–
No data for this company
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
28
28 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
28×
28 articles in the last 7 days; its usual week has 1.
Unusual now sharp changes in the last 90 days, compared with its own past
Revenue $41.5M, 2.5× a year earlier
Price $7.95 on 20 Nov 2026, -40% over 12 months (12-month range $7.95 to $29.63)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders bought a net $1.2M in the last 12 months (the 12 months before: -$213K).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 3 published in the last 12 months (none in the 12 months before).Revenue per quarter. Revenue $41.5M in the latest quarter, +148% on a year earlier.Capital spending per quarter. Capital spending $3.1M in the latest quarter.Institutional holders (13F filers). 50 13F filers reported holding it in the latest 13F quarter, +4900% on a year earlier.Lobbying spend. Lobbying spend: $0 published in the last 12 months, -100% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.
In 12 months: 6 major agreements, 5 director or officer changes, 1 restructuring. Results releases and routine reports are left out.
Filed
What happened
Source
18 Nov 2026
Entered two private placements: common stock at $8.00/share (about $153.0M expected) and up to $500M of Series C Preferred under a PEPASame filing: took on new debt, sold shares privately, changed its bylaws or fiscal year, shareholder vote results
Reported lobbying spend: $10K in Q3 2025, $10K in Q2 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Research, development and acquisition of robotic exoskeletons.; FY18 Military Construction, Veterans Affairs Appropriations bill--robotic exoskeletons used for stroke and spinal cord injury rehabilitationVET, Budget, Defense
Changes and notable records, by the date each became public
15 Oct 2026Financials change
reported revenue of $41.5M for the quarter ended 31 Aug 2026, 2.5× the same quarter last year.
Same quarter last year: $16.7M; its normal quarter is $3.8M.
See the evidence
This period
$41.5M (the quarter ended 31 Aug 2026)
Normal quarter (median of 8 earlier)
$3.8M
Typical spread (median absolute deviation)
$975K
How far from its usual level
+26.1
Same quarter last year
$16.7M
History used
3,805 days
the quarter ended 31 Aug 20268 earlier quartersnormal: $3.8M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Showing the newest 40 of 79 entries; narrow the window or the kind of data to see older ones.
Not listed: 198 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001549084
Ticker
CHRN
Domain
chronoscale.com
Employer name
chronoscale (1 unverified)
Hq location
CA|MENLO PARK|94025 (1 unverified)
Lobbying client
ekso bionics
Name
ChronoScale Corp, ChronoScale Holdings Corporation, ChronoScale Intermediate LLC, Ekso Bionics (Asia) Pte. Ltd and 4 more
DOL H-1B labor condition applications and PERM certifications5 data points14 Sep 2026 to 14 Sep 2026
Federal lobbying disclosures (LDA)5 records, 104 data points1 Jun 2012 to 30 Sep 2026
SEC Form 13F institutional holdings27 data points31 Mar 2026 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)210 records26 Feb 2016 to 18 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1104 data points31 Dec 2011 to 13 Oct 2026
SEC Form 4 insider transactions51 records, 164 data points15 Nov 2016 to 20 Mar 2026
FINRA short interest (twice monthly)36 data points15 May 2026 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)280 data points5 May 2026 to 20 Nov 2026